Bayer België - Bayer Belgique

Science for a better life

1 - 10 11 - 20 21 - 30 31 - 40 41 - 50 51 - 60 61 - 70 71 - 80 81 - 90 91 - 100 101 - 110 111 - 111

10 november 2019

Climate FieldView™ Partnership with CLAAS Brings Bayer Data Science to More Farms:

Global agreement supports FieldView expansion in Europe and other regions
meer

30 oktober 2019

Quaterly Statements / Half-Year Reports

Encouraging business performance across all divisions - agreements signed to divest Currenta and Animal Health

Group sales increase by 5.4 percent (Fx & portfolio adj.) to 9.830 billion euros
EBITDA before special items advances by 7.5 percent to 2.291 billion euros
Crop Science reports higher sales and substantial earnings growth
Pharmaceuticals increases sales – earnings decline due to one-time income in prior year
Consumer Health posts growth in sales (Fx & portfolio adj.) and earnings
Net income declines by 63.9 percent to 1.036 billion euros – substantial divestment gain included in prior year
Core earnings per share up by 6.4 percent to 1.16 euros
Group outlook confirmed and aligned to continuing operations
meer

21 oktober 2019

Bayer at the Annual Biocontrol Industry Meeting 2019:

“Biologicals by Bayer”, leading innovation for organic crop protection solutions
meer

01 oktober 2019

Future of Farming Dialogue hosted by Bayer:

Bayer committed to shaping a more sustainable food system

Agriculture is part of the solution for climate change
Investing more than 25 billion euros in Crop Science R&D over the next 10 years
Leading Digital Farming platform FieldView on 90 million paid acres this year
meer

20 augustus 2019

Bayer to sell its Animal Health business unit to Elanco for 7.6 billion U.S. dollars
meer

08 augustus 2019

News Release

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Implied total company value of up to USD 1 billion, inclusive of 40.8 percent stake currently held by Bayer
Initial focus in neurology, cardiology, and immunology with start of first clinical program in Parkinson’s disease expected later this year
BlueRock Therapeutics to continue to operate as an independent company
meer

03 juli 2019

Persbericht

Qlaira® toont een hoge werkzaamheid en een positief veiligheidsprofiel in real world studies met meer dan 50.000 vrouwen
meer

26 juni 2019

Newsflash

Bayer Supervisory Board takes action to address the glyphosate litigation and welcomes the appointment of Ken Feinberg as mediator
meer

18 juni 2019

Bayer kondigt een vijfjarig partnerschap aan met het Humanitaire Hulpprogramma van de World Federation of Hemophilia

De donatie van factor VIII-behandelingen zal maar liefst 5000 mensen met hemofilie A helpen in landen met onvoldoende toegang tot zorgverlening.
Het partnerschap omvat een schenking van 50 miljoen internationale eenheden van de factor VIII-behandeling in 2019.
Het programma ondersteunt de training, voorlichting en levering van factor VIII-behandelingen aan professionele zorgverleners in meer dan 60 landen.
meer

14 juni 2019

NEWSFLASH

Bayer raises the bar in transparency, sustainability and engagement

With its solutions, the company aims to reduce environmental impact by 30 percent
Approximately 5 billion euros will be invested in additional methods to combat weeds over the next decade
Invitation to scientists, journalists and NGO representatives to participate in the scientific preparation for the upcoming EU glyphosate re-registration process
Crop protection products will only be sold in developing countries if they meet the standards of a majority of leading regulators on top of local regulations
meer

1 - 10 11 - 20 21 - 30 31 - 40 41 - 50 51 - 60 61 - 70 71 - 80 81 - 90 91 - 100 101 - 110 111 - 111